Baby Boomers are increasingly turning to supplements like omega-3s, magnesium, calcium, and CBD to support their health as they age. With the aging population and growing interest in longevity, the market for healthy aging products is ripe for innovation. The health and nutrition industry must prioritize cognitive health, ingredients that promote activity and wellness, and bone health.
According to the Transamerica Retirement Survey of 2013, ten thousand Baby Boomers turn 65 every day. This generation is not only growing older but also living longer. By 2050, the U.S. population aged 65 and over is projected to reach 83.7 million, nearly double the 2012 estimate of 43.1 million, as reported by the U.S. Census Bureau. This trend has led Baby Boomers to embrace the idea that 70 is the new 60 and 80 is the new 70. A 2009 Pew Research survey found that the typical Boomer believes old age does not begin until age 72. Additionally, 61% of Boomers feel younger than their actual age, and 65% plan to work past age 65. This may be due to increased life expectancy, financial concerns, or support for adult children. As a result, people are seeking supplements to enhance daily life and longevity. Omega-3 fatty acids DHA and EPA: Derived from sources like plants, beef, seeds, and especially fish and seafood, these supplements offer benefits such as reducing triglycerides, relieving rheumatoid arthritis symptoms, and slowing age-related macular degeneration. Magnesium: This mineral supports bone health, the cardiovascular system, diabetes management, and other bodily functions. It may also help with migraines and reduce anxiety. Good food sources include almonds, spinach, peanut butter, bananas, and black beans. Calcium: Essential for bone health, calcium is crucial for active aging populations like Baby Boomers and Millennials. It also helps protect against colon cancer and aids in weight control.Vitamin D: A lack of Vitamin D due to poor diets or lack of sunshine because the population is either working or living mostly indoors has become a real issue for the aging population’s health. Several studies link low vitamin D levels with an increased risk of fractures in older adults. Vitamin D in high dosages has been proven to help protect against heart disease and cancer, and help with the development of muscle, a critical factor in mobility as we grow older.
CBD: Cannabidiol (CBD) is a chemical compound from the cannabis plant. It is a naturally occurring substance used in products like oils and edibles. Unlike its cousin tetrahydrocannabinol (THC), it is not psychoactive. With the passage of the 2018 Farm Bill and the removal of industrial hemp from the controlled substance list and the use of the word CBD finding its way into the lexicon of the average consumer, the CBD market has exploded. What started as mostly a grassroots movement only five years ago has now ballooned to a potential market for CBD projected to be $22 billion by 2020, according to the Brightfield Group [link ‘the Brightfield Group’ to https://www.brightfieldgroup.com/post/hemp-cbd-market-to-reach-22-billion-by-2022]. While much research is still to be done, and the legal landscape surrounding CBD must still be vetted on a state by state basis, the health benefits of CBD are wide ranging. Some of the purported health benefits of CBD include relief from anxiety, inflammatory conditions, acne, diabetes, cancer and Alzheimer’s disease. As our population continues to live longer, it is important to maintain a healthy lifestyle. Supplements such as magnesium, calcium and vitamin D have proven for years to help in longevity while recent studies of CBD have outlined benefits as well. Matthew Smith, Counsel to Hoban Law Group (hoban.law) has a long history with the cannabis industry dating back to the 1990s. Matthew’s first career was as a physicist. This combined with his experience of being in business, including cannabis businesses, and his training as a teacher, gives him an ability to analyze issues, solve problems, explain what is happening to clients, and do so in a cost-effective way. Smith has extensive corporate and transactional experience, including corporate structuring, capital raises, acquisitions, and contract drafting. This article has been prepared for informational and general guidance purposes only; it does not constitute legal or professional advice. You should not act upon the information contained herein without obtaining specific professional advice. No representation or warranty (express or implied) is made to the accuracy or completeness of the information contained in this publication. Hoban Law Group, its members, employees and agents accept no liability and disclaim all responsibility, for the consequences of you or anyone else acting, or refraining to act, in reliance on the information contained in this publication or for any decision based thereupon.Wang C et al. “n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review.” Am J Clin Nutr 2006;84:5-17.
Park Y et al. “Effect of n-3 polyunsaturated fatty acid supplementation in patients with rheumatoid arthritis: a 16-week randomized, double-blind, placebo-controlled, parallel-design multicenter study in Korea.” J Nutr Biochem 2013;24:1367-7. Christen W. “Dietary omega-3 fatty acid and fish intake and incident age-related macular degeneration in women.” Arch Ophthalmol 2011;129:921-9. Sun-Edelstein C, Mauskop A. “Role of magnesium in the pathogenesis and treatment of migraine.” Expert Rev Neurother 2009;9:369–79. Pyndt Jørgensen B et al. “Dietary magnesium deficiency affects gut microbiota and anxiety-like behaviour in C57BL/6N mice.” Acta Neuropsychiatr. 2015 Oct;27(5):307-11. DOI: 10.1017/neu.20110. Heaney R et al. “Calcium absorption in women: relationships to calcium intake, estrogen status, and age.” J Bone Miner Res 1989;4:469-75. Kampman E. “Calcium, vitamin D, sunshine exposure, dairy products, and colon cancer risk.” Cancer Causes Control 2000;11:459-66. Davies K. et al. “Calcium intake and body weight.” J Clin Endocrinol Metab 2000;85:4635-8. Boonen S et al. “Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: evidence from a comparative metaanalysis of randomized controlled trials.” J Clin Endocrinol Metab. 2007; 92:1415-23. Giovannucci E et al. “25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study.” Arch Intern Med. 2008; 168:1174-80. Gorham E et al. “Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis.” Am J Prev Med. 2007; 32:210-6. Bischoff-Ferrari H et al. “Effect of Vitamin D on falls: a meta-analysis.” JAMA. 2004; 291:1999-2006. Blessing E et al. “Cannabidiol as a Potential Treatment for Anxiety Disorders.” Neurotherapeutics. 2015 Oct; 12(4): 825–836. DOI: 10.1007/s13311-015-0387-1. Lehmann C et al. “Experimental cannabidiol treatment reduces early pancreatic inflammation in type 1 diabetes.” Clinical Hemorheology and Microcirculation. 2017 Feb 2; 64(4):655-662, 2016. Oláh A. et al. “Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes.” J Clin Invest. 2014 Sep 2; 124(9): 3713–3724. DOI: 10.1172/JCI64628. Lehmann C et al. “Experimental cannabidiol treatment reduces early pancreatic inflammation in type 1 diabetes.” Clin Hemorheol Microcirc. 2016;64(4):655-662. DOI: 10.3233/CH-168021. Massi P et al. “Cannabidiol as potential anticancer drug.” Br J Clin Pharmacol. 2013 Feb; 75(2): 303–312. DOI: 10.1111/j.1365-2125.2012.04298.x. Cheng D et al. “Long-Term Cannabidiol Treatment Prevents the Development of Social Recognition Memory Deficits in Alzheimer’s Disease Transgenic Mice.” J Alzheimers Dis. 2014;42(4):1383-96. DOI: 10.3233/JAD-140921.
